Rich Pharmaceuticals Inc (RCHA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Rich Pharmaceuticals Inc (RCHA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH507906D
  • |
  • Pages: 35
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Rich Pharmaceuticals Inc (Rich Pharmaceuticals) is a biopharmaceutical company that focuses on the discovery and development of therapies for the treatment of cancer and neurological disorders. Its pipeline portfolio offers a lead drug candidate for the treatment of acute myeloid leukemia (AML) called RP-323 (12-O- tetradecanoyl- phorbol-13-acetate) (TPA) and undergoing phase II clinical trials. RP-323 can also be used for the treatment of Hodgkin's lymphoma (HL). The company works in collaboration with non-profit institutes to develop technologies. Rich Pharmaceuticals is headquartered in Beverly Hills, California, the US.

Rich Pharmaceuticals Inc (RCHA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Rich Pharma to Acquire Patents for Treatment of Hodgkin's Lymphoma from Richard l. Chang and Imagic 12

Rich Pharma to Acquire Certain Assets from Imagic 12

Partnerships 13

Rich Pharma Partners with Theradex Systems 13

Rich Pharma Partners with CMIC Asia-Pacific 14

Rich Pharma Extends Agreement with Theradex Systems 14

Equity Offering 15

Rich Pharma to Raise up to USD2 Million in Private Placement of Shares 15

Rich Pharma to Raise USD4.5 Million in Private Placement of Common Stock 16

Rich Pharma Completes Public Offering Of Shares For US$0.4 Million 17

Rich Pharma Raises USD0.3 Million in Private Placement of Units 18

Rich Pharma Raises Funds in Private Placement of Units 18

Debt Offering 19

Rich Pharma Raises Funds through Private Placement of 8% Notes Due 2016 19

Rich Pharma Raises Funds through Private Placement of 8% Notes Due 2016 19

Rich Pharma Raises USD0.1 Million in Private Placement of 8% Notes Due 2016 20

Rich Pharma Raises Funds in Private Placement of 8% Notes 21

Rich Pharma Raises Funds in Private Placement of 8% Notes Due 2015 21

Rich Pharma Raises Funds in Private Placement of 8% Notes Due 2015 22

Rich Pharma Raises Funds in Private Placement of 8% Notes Due 2015 23

Rich Pharma Raises Funds in Private Placement of 8% Notes Due 2015 24

Rich Pharma Raises Funds in Private Placement of 8% Notes Due 2015 24

Rich Pharma Raises Funds in Private Placement of Notes Due 2015 25

Rich Pharma Raises USD0.5 Million in Private Placement of Notes 26

Rich Pharma Raises USD0.4 Million in Private Placement of Notes 27

Rich Pharmaceuticals Inc-Key Competitors 28

Key Employees 29

Locations And Subsidiaries 30

Head Office 30

Recent Developments 31

Strategy And Business Planning 31

Feb 16, 2016: Rich Pharmaceuticals Highlights Goals and Objectives for 2016 31

Financial Announcements 32

Apr 06, 2017: Rich Pharmaceuticals announces Industry Veteran to Join CannCodex 32

Corporate Communications 33

Apr 10, 2017: Rich Pharmaceuticals Welcomes New Board Member 33

Other Significant Developments 34

Sep 27, 2016: Rich Pharmaceuticals Announces Quarterly Milestones 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

List of Tables

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Rich Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 9

Rich Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Rich Pharma to Acquire Patents for Treatment of Hodgkin's Lymphoma from Richard l. Chang and Imagic 12

Rich Pharma to Acquire Certain Assets from Imagic 12

Rich Pharma Partners with Theradex Systems 13

Rich Pharma Partners with CMIC Asia-Pacific 14

Rich Pharma Extends Agreement with Theradex Systems 14

Rich Pharma to Raise up to USD2 Million in Private Placement of Shares 15

Rich Pharma to Raise USD4.5 Million in Private Placement of Common Stock 16

Rich Pharma Completes Public Offering Of Shares For US$0.4 Million 17

Rich Pharma Raises USD0.3 Million in Private Placement of Units 18

Rich Pharma Raises Funds in Private Placement of Units 18

Rich Pharma Raises Funds through Private Placement of 8% Notes Due 2016 19

Rich Pharma Raises Funds through Private Placement of 8% Notes Due 2016 19

Rich Pharma Raises USD0.1 Million in Private Placement of 8% Notes Due 2016 20

Rich Pharma Raises Funds in Private Placement of 8% Notes 21

Rich Pharma Raises Funds in Private Placement of 8% Notes Due 2015 21

Rich Pharma Raises Funds in Private Placement of 8% Notes Due 2015 22

Rich Pharma Raises Funds in Private Placement of 8% Notes Due 2015 23

Rich Pharma Raises Funds in Private Placement of 8% Notes Due 2015 24

Rich Pharma Raises Funds in Private Placement of 8% Notes Due 2015 24

Rich Pharma Raises Funds in Private Placement of Notes Due 2015 25

Rich Pharma Raises USD0.5 Million in Private Placement of Notes 26

Rich Pharma Raises USD0.4 Million in Private Placement of Notes 27

Rich Pharmaceuticals Inc, Key Competitors 28

Rich Pharmaceuticals Inc, Key Employees 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Rich Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16863
Site License
USD 500 INR 33725
Corporate User License
USD 750 INR 50588

NEWSLETTER BY CATEGORY




Testimonials

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com